Fracture Risk in CKD Not Higher With SGLT2 Inhibitors - Rheumatology Advisor

Patients with CKD are vulnerable to fractures due to CKD mineral bone disorder.

Some clinical trials have linked sodium-glucose cotransporter-2 (SGLT2) inhibitors to a higher risk for skeletal fractures. In contrast to this research, a new study finds that SGLT2 inhibitors pose … [+3632 chars]

full article...